Jacobs Levy Equity Management, Inc Surmodics Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $2.83 Million - $4.7 Million	-111,629 Reduced 91.68%	10,124 $425,000
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $170,457 - $220,898	-6,212 Reduced 4.85%	121,753 $3.57 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $337,170 - $455,837	-11,843 Reduced 8.47%	127,965 $4.65 Million
Q3 2023 Nov 16, 2023	SELL	$28.28 - $38.36 $569,474 - $772,455	-20,137 Reduced 12.59%	139,808 $4.49 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $834,041 - $1.48 Million	47,201 Added 41.87%	159,945 $5.01 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $1.38 Million - $3.09 Million	80,296 Added 247.46%	112,744 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$29.44 - $37.31 $232,399 - $294,525	-7,894 Reduced 19.57%	32,448 $1.11 Million
Q3 2022 Nov 15, 2022	SELL	$28.84 - $38.92 $536,683 - $724,262	-18,609 Reduced 31.57%	40,342 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$33.25 - $45.11 $302,575 - $410,501	-9,100 Reduced 13.37%	58,951 $2.2 Million
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $137,701 - $168,302	-3,385 Reduced 4.74%	68,051 $3.09 Million
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $511,433 - $681,753	-11,836 Reduced 14.21%	71,436 $3.44 Million
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $1.18 Million - $1.35 Million	-22,322 Reduced 21.14%	83,272 $4.63 Million
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $352,413 - $406,419	6,871 Added 6.96%	105,594 $5.73 Million
Q1 2021 May 17, 2021	SELL	$42.18 - $56.07 $62,173 - $82,647	-1,474 Reduced 1.47%	98,723 $5.54 Million
Q4 2020 Feb 16, 2021	SELL	$35.18 - $43.52 $946,834 - $1.17 Million	-26,914 Reduced 21.17%	100,197 $4.36 Million
Q3 2020 Nov 16, 2020	SELL	$37.98 - $48.72 $442,884 - $568,123	-11,661 Reduced 8.4%	127,111 $4.95 Million
Q2 2020 Aug 17, 2020	BUY	$31.07 - $44.74 $18,766 - $27,022	604 Added 0.44%	138,772 $6 Million
Q1 2020 May 15, 2020	SELL	$22.46 - $42.24 $73,758 - $138,716	-3,284 Reduced 2.32%	138,168 $4.6 Million
Q4 2019 Feb 14, 2020	BUY	$39.01 - $47.51 $783,008 - $953,620	20,072 Added 16.54%	141,452 $5.86 Million
Q3 2019 Nov 14, 2019	BUY	$38.66 - $47.41 $525,389 - $644,301	13,590 Added 12.61%	121,380 $5.55 Million
Q2 2019 Aug 13, 2019	BUY	$38.23 - $47.43 $26,760 - $33,201	700 Added 0.65%	107,790 $4.65 Million
Q1 2019 May 14, 2019	BUY	$41.26 - $58.35 $1.45 Million - $2.06 Million	35,250 Added 49.07%	107,090 $4.66 Million
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $92,555 - $151,162	2,060 Added 2.95%	71,840 $3.4 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $871,339 - $1.23 Million	15,327 Added 28.15%	69,780 $5.21 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $831,720 - $1.32 Million	23,200 Added 74.23%	54,453 $3.01 Million
Q1 2018 May 15, 2018	SELL	$27.0 - $38.5 $46,467 - $66,258	-1,721 Reduced 5.22%	31,253 $1.19 Million
Q4 2017 Feb 13, 2018	BUY	$28.0 - $33.2 $85,960 - $101,924	3,070 Added 10.27%	32,974 $923,000
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $135,975 - $172,605	5,550 Added 22.79%	29,904 $927,000
Q2 2017 Nov 09, 2017	BUY	N/A	24,354	24,354 $686,000

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

12M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$44.6 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$39.6 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$37.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$30.6 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$28.7 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account